SK+F
| Company type | Private Limited |
|---|---|
| Industry | Pharmaceutical |
| Founded | 1990 |
| Headquarters | Gulshan, , Bangladesh |
| Website | skfbd |
Eskayef Pharmaceuticals Ltd., also known as SK+F, is one of top leading pharmaceutical companies in Bangladesh. It belongs to the Transcom Group.[1][2] Ms Simeen Hossain is the managing director & CEO of the company.[2][3]
History
Eskayef Bangladesh Limited (SK+F), a successor of Smith, Kline & French in Bangladesh, was acquired by Transcom in 1990.[2] According IMS report, the company placed among the top six pharmaceutical companies operating in Bangladesh in terms of sales.[4] It exports finished products to more than 30 countries across 4 continents including Asia, Europe, Australia and Africa.[2] The company was renamed Eskayef Pharmaceuticals Limited in January 2017.[5]
The company is engaged in the manufacture and marketing of a wide range of therapeutic drugs, bulk pellets and animal health and nutrition products.[6]
References
- ^ Iqbal, Farah K. (2016-09-19). "What makes the market tick?". Dhaka Tribune (Op-ed). Retrieved 2016-10-03.
- ^ a b c d "Eskayef sales jump manifold". The Daily Star. 2015-12-29. Retrieved 2016-10-03.
- ^ "'I am the brand'". Prothom Alo. Retrieved 2016-10-03.
- ^ Akter, Sayeda (2009-08-23). "Pharma industry set for expansion". The Daily Star. Retrieved 2016-10-03.
- ^ "Eskayef pledges to conquer odds with courage". The Daily Star. 2017-01-24.
- ^ "Eskayef beats rivals in sales growth". The Daily Star. 2012-01-26.
Further reading
- Rahman, Md Fazlur (2015-03-24). "Novo Nordisk: Ethically profitable". The Daily Star. Retrieved 2016-10-03.
External links
 | This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it. |